A Multicenter Consortium to Define the Epidemiology and Outcomes of Pediatric Solid Organ Transplant Recipients With Inpatient Respiratory Virus Infection

Lara Danziger-Isakov, William J Steinbach, Grant Paulsen, Flor M Munoz, Leigh R Sweet, Michael Green, Marian G Michaels, Janet A Englund, Alastair Murray, Natasha Halasa, Daniel E Dulek, Rebecca Pellett Madan, Betsy C Herold, Brian T Fisher, Lara Danziger-Isakov, William J Steinbach, Grant Paulsen, Flor M Munoz, Leigh R Sweet, Michael Green, Marian G Michaels, Janet A Englund, Alastair Murray, Natasha Halasa, Daniel E Dulek, Rebecca Pellett Madan, Betsy C Herold, Brian T Fisher

Abstract

Background: Respiratory virus infection (RVI) in pediatric solid organ transplant (SOT) recipients poses a significant risk; however, the epidemiology and effects of an RVI after pediatric SOT in the era of current molecular diagnostic assays are unclear.

Methods: A retrospective observational cohort of pediatric SOT recipients (January 2010 to June 2013) was assembled from 9 US pediatric transplant centers. Charts were reviewed for RVI events associated with hospitalization within 1 year after the transplant. An RVI diagnosis required respiratory symptoms and detection of a virus (ie, human rhinovirus/enterovirus, human metapneumovirus, influenza virus, parainfluenza virus, coronavirus, and/or respiratory syncytial virus). The incidence of RVI was calculated, and the association of baseline SOT factors with subsequent pulmonary complications and death was assessed.

Results: Of 1096 pediatric SOT recipients (448 liver, 289 kidney, 251 heart, 66 lung, 42 intestine/multivisceral), 159 (14.5%) developed RVI associated with hospitalization within 12 months after their transplant. RVI occurred at the highest rates in intestine/abdominal multivisceral (38%), thoracic (heart/lung) (18.6%), and liver (15.6%) transplant recipients and a lower rate in kidney (5.5%) transplant recipients. RVI was associated with younger median age at transplant (1.72 vs 7.89 years; P < .001) and among liver or kidney transplant recipients with the receipt of a deceased-donor graft compared to a living donor (P = .01). The all-cause and attributable case-fatality rates within 3 months of RVI onset were 4% and 0%, respectively. Multivariable logistic regression models revealed that age was independently associated with increased risk for a pulmonary complication (odds ratio, 1.24 [95% confidence interval, 1.02-1.51]) and that receipt of an intestine/multivisceral transplant was associated with increased risk of all-cause death (odds ratio, 24.54 [95% confidence interval, 1.69-327.96]).

Conclusions: In this study, hospital-associated RVI was common in the first year after pediatric SOT and associated with younger age at transplant. All-cause death after RVI was rare, and no definitive attributable death occurred.

Keywords: organ transplantation; pediatrics; respiratory virus infection.

© The Author(s) 2018. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Figures

Figure 1.
Figure 1.

References

    1. US Department of Health and Human Services, Health Resources and Services Administration, Maternal and Child Health Bureau. Child health USA 2012. US Department of Health and Human Services, ed. Rockville, MD: US Department of Health and Human Services; 2013.
    1. Flagg A, Danziger-Isakov L, Foster C et al. . Novel 2009 H1N1 influenza virus infection requiring extracorporeal membrane oxygenation in a pediatric heart transplant recipient. J Heart Lung Transplant 2010; 29:582–4.
    1. Evashuk KM, Forgie SE, Gilmour S et al. . Respiratory failure associated with human metapneumovirus infection in an infant posthepatic transplant. Am J Transplant 2008; 8:1567–9.
    1. Blanchard SS, Gerrek M, Siegel C, Czinn SJ. Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: case report and discussion regarding need of routine prophylaxis. Pediatr Transplant 2006; 10:826–9.
    1. Gavaldà J, Cabral E, Alonso E et al. . Influenza A H1N1/2009 infection in pediatric solid organ transplant recipients. Transpl Infect Dis 2012; 14:584–8.
    1. Lo MS, Lee GM, Gunawardane N et al. . The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy. Pediatr Transplant 2013; 17:133–43.
    1. Tran TT, Gonzalez IA, Tekin A, McLaughlin GE. Lower respiratory tract viral infections in pediatric abdominal organ transplant recipients: a single hospital inpatient cohort study. Pediatr Transplant 2013; 17:461–5.
    1. Robinson JL, Grenier D, MacLusky I, Allen UD. Respiratory syncytial virus infections in pediatric transplant recipients: a Canadian Paediatric Surveillance Program study. Pediatr Transplant 2015; 19:659–62.
    1. Kumar D, Michaels MG, Morris MI et al. ; American Society of Transplantation H1N1 Collaborative Study Group Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10:521–6.
    1. Liu M, Worley S, Arrigain S et al. . Respiratory viral infections within one year after pediatric lung transplant. Transpl Infect Dis 2009; 11:304–12.
    1. Fisher BT, Danziger-Isakov L, Sweet LR et al. . A multicenter consortium to define the epidemiology and outcomes of inpatient respiratory viral infections in pediatric hematopoietic stem cell transplant recipients. J Pediatric Infect Dis Soc 2017.
    1. Fisher CE, Preiksaitis CM, Lease ED et al. . Symptomatic respiratory virus infection and chronic lung allograft dysfunction. Clin Infect Dis 2016; 62:313–9.
    1. Sayah DM, Koff JL, Leard LE et al. . Rhinovirus and other respiratory viruses exert different effects on lung allograft function that are not mediated through acute rejection. Clin Transplant 2013; 27:E64–71.
    1. Apalsch AM, Green M, Ledesma-Medina J et al. . Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995; 20:394–9.
    1. Kumar D, Michaels MG, Morris MI et al. ; American Society of Transplantation H1N1 Collaborative Study Group Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10:521–6.
    1. Liu M, Mallory GB, Schecter MG et al. . Long-term impact of respiratory viral infection after pediatric lung transplantation. Pediatr Transplant 2010; 14:431–6.
    1. Bridges ND, Spray TL, Collins MH et al. . Adenovirus infection in the lung results in graft failure after lung transplantation. J Thorac Cardiovasc Surg 1998; 116:617–23.
    1. Chu HY, Chin J, Pollard J et al. . Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children. Influenza Other Respir Viruses 2016; 10:205–10.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅